Skip to main content
Journal cover image

Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity.

Publication ,  Journal Article
Green, JB; Feinglos, MN
Published in: Curr Diab Rep
October 2007

Diabetes mellitus and obesity have become increasingly prevalent problems worldwide. Unfortunately, with traditionally prescribed glucose-lowering medications most individuals with diagnosed diabetes do not achieve and maintain adequate glycemic control over time; it may be even more challenging to lower blood glucose to an appropriate level without inducing a significant associated weight gain. Exenatide and rimonabant are recently developed agents that have demonstrated benefit in both glucose lowering and reduction of body weight. These medications may well prove to be attractive alternatives or additions to our more established diabetes therapies; however, these drugs have a side-effect profile that may limit their applicability to certain populations.

Duke Scholars

Published In

Curr Diab Rep

DOI

ISSN

1534-4827

Publication Date

October 2007

Volume

7

Issue

5

Start / End Page

369 / 375

Location

United States

Related Subject Headings

  • Venoms
  • Rimonabant
  • Pyrazoles
  • Piperidines
  • Peptides
  • Obesity
  • Hypoglycemic Agents
  • Humans
  • Exenatide
  • Endocrinology & Metabolism
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Green, J. B., & Feinglos, M. N. (2007). Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity. Curr Diab Rep, 7(5), 369–375. https://doi.org/10.1007/s11892-007-0060-0
Green, Jennifer B., and Mark N. Feinglos. “Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity.Curr Diab Rep 7, no. 5 (October 2007): 369–75. https://doi.org/10.1007/s11892-007-0060-0.
Green, Jennifer B., and Mark N. Feinglos. “Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity.Curr Diab Rep, vol. 7, no. 5, Oct. 2007, pp. 369–75. Pubmed, doi:10.1007/s11892-007-0060-0.
Journal cover image

Published In

Curr Diab Rep

DOI

ISSN

1534-4827

Publication Date

October 2007

Volume

7

Issue

5

Start / End Page

369 / 375

Location

United States

Related Subject Headings

  • Venoms
  • Rimonabant
  • Pyrazoles
  • Piperidines
  • Peptides
  • Obesity
  • Hypoglycemic Agents
  • Humans
  • Exenatide
  • Endocrinology & Metabolism